Acne Vulgaris Treatment Market Report

Global and Region Acne Vulgaris Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：186
  • REPORT CODE：GMM904993
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Acne Vulgaris Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Acne Vulgaris Treatmentmarket, defines the market attractiveness level of Acne Vulgaris Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Acne Vulgaris Treatment industry, describes the types of Acne Vulgaris Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acne Vulgaris Treatment market and the development prospects and opportunities of Acne Vulgaris Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acne Vulgaris Treatment market in Chapter 13.

    By Player:

    • Ensol Biosciences Inc

    • Pfizer Inc

    • Phosphagenics Ltd

    • ELORAC Inc

    • Dermira Inc

    • Cutanea Life Sciences Inc

    • Foamix Pharmaceuticals Ltd

    • Galderma SA

    • LEO Pharma A/S

    • Hovione FarmaCiencia SA

    • Novabiotics Ltd

    • GlaxoSmithKline Plc

    • Lee's Pharmaceutical Holdings Ltd

    • Helix BioMedix Inc

    • Paratek Pharmaceuticals Inc

    • Novartis AG

    • Common Pharma Inc

    • Novan Inc

    By Type:

    • CB-0601

    • CJM-112

    • CLS-007

    • Dapsone

    • DFD-10

    • DLX-2323

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Acne Vulgaris Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Acne Vulgaris Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Acne Vulgaris Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Acne Vulgaris Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Acne Vulgaris Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Acne Vulgaris Treatment Consumption (2017-2022)

    • 7.2 United States Acne Vulgaris Treatment Consumption (2017-2022)

    • 7.3 Europe Acne Vulgaris Treatment Consumption (2017-2022)

    • 7.4 China Acne Vulgaris Treatment Consumption (2017-2022)

    • 7.5 Japan Acne Vulgaris Treatment Consumption (2017-2022)

    • 7.6 India Acne Vulgaris Treatment Consumption (2017-2022)

    • 7.7 South Korea Acne Vulgaris Treatment Consumption (2017-2022)

    8 Region and Country-wise Acne Vulgaris Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 8.4 China Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 8.6 India Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Acne Vulgaris Treatment Consumption Forecast (2022-2028)

    9 Global Acne Vulgaris Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Acne Vulgaris Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CB-0601 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CJM-112 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CLS-007 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Dapsone Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global DFD-10 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global DLX-2323 Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Acne Vulgaris Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Acne Vulgaris Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Acne Vulgaris Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CB-0601 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CJM-112 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CLS-007 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Dapsone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global DFD-10 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global DLX-2323 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Acne Vulgaris Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Acne Vulgaris Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Acne Vulgaris Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Acne Vulgaris Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Acne Vulgaris Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Acne Vulgaris Treatment Market Competitive Analysis

    • 14.1 Ensol Biosciences Inc

      • 14.1.1 Ensol Biosciences Inc Company Details

      • 14.1.2 Ensol Biosciences Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Ensol Biosciences Inc Acne Vulgaris Treatment Product and Service

    • 14.2 Pfizer Inc

      • 14.2.1 Pfizer Inc Company Details

      • 14.2.2 Pfizer Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Inc Acne Vulgaris Treatment Product and Service

    • 14.3 Phosphagenics Ltd

      • 14.3.1 Phosphagenics Ltd Company Details

      • 14.3.2 Phosphagenics Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Phosphagenics Ltd Acne Vulgaris Treatment Product and Service

    • 14.4 ELORAC Inc

      • 14.4.1 ELORAC Inc Company Details

      • 14.4.2 ELORAC Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 ELORAC Inc Acne Vulgaris Treatment Product and Service

    • 14.5 Dermira Inc

      • 14.5.1 Dermira Inc Company Details

      • 14.5.2 Dermira Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Dermira Inc Acne Vulgaris Treatment Product and Service

    • 14.6 Cutanea Life Sciences Inc

      • 14.6.1 Cutanea Life Sciences Inc Company Details

      • 14.6.2 Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Product and Service

    • 14.7 Foamix Pharmaceuticals Ltd

      • 14.7.1 Foamix Pharmaceuticals Ltd Company Details

      • 14.7.2 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product and Service

    • 14.8 Galderma SA

      • 14.8.1 Galderma SA Company Details

      • 14.8.2 Galderma SA Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Galderma SA Acne Vulgaris Treatment Product and Service

    • 14.9 LEO Pharma A/S

      • 14.9.1 LEO Pharma A/S Company Details

      • 14.9.2 LEO Pharma A/S Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 LEO Pharma A/S Acne Vulgaris Treatment Product and Service

    • 14.10 Hovione FarmaCiencia SA

      • 14.10.1 Hovione FarmaCiencia SA Company Details

      • 14.10.2 Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Product and Service

    • 14.11 Novabiotics Ltd

      • 14.11.1 Novabiotics Ltd Company Details

      • 14.11.2 Novabiotics Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novabiotics Ltd Acne Vulgaris Treatment Product and Service

    • 14.12 GlaxoSmithKline Plc

      • 14.12.1 GlaxoSmithKline Plc Company Details

      • 14.12.2 GlaxoSmithKline Plc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Product and Service

    • 14.13 Lee's Pharmaceutical Holdings Ltd

      • 14.13.1 Lee's Pharmaceutical Holdings Ltd Company Details

      • 14.13.2 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product and Service

    • 14.14 Helix BioMedix Inc

      • 14.14.1 Helix BioMedix Inc Company Details

      • 14.14.2 Helix BioMedix Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Helix BioMedix Inc Acne Vulgaris Treatment Product and Service

    • 14.15 Paratek Pharmaceuticals Inc

      • 14.15.1 Paratek Pharmaceuticals Inc Company Details

      • 14.15.2 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product and Service

    • 14.16 Novartis AG

      • 14.16.1 Novartis AG Company Details

      • 14.16.2 Novartis AG Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Novartis AG Acne Vulgaris Treatment Product and Service

    • 14.17 Common Pharma Inc

      • 14.17.1 Common Pharma Inc Company Details

      • 14.17.2 Common Pharma Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Common Pharma Inc Acne Vulgaris Treatment Product and Service

    • 14.18 Novan Inc

      • 14.18.1 Novan Inc Company Details

      • 14.18.2 Novan Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Novan Inc Acne Vulgaris Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Acne Vulgaris Treatment

    • Figure Acne Vulgaris Treatment Picture

    • Table Global Acne Vulgaris Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Acne Vulgaris Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Acne Vulgaris Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Acne Vulgaris Treatment Consumption by Country (2017-2022)

    • Figure United States Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Acne Vulgaris Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Acne Vulgaris Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Acne Vulgaris Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CB-0601 Consumption and Growth Rate (2017-2022)

    • Figure Global CJM-112 Consumption and Growth Rate (2017-2022)

    • Figure Global CLS-007 Consumption and Growth Rate (2017-2022)

    • Figure Global Dapsone Consumption and Growth Rate (2017-2022)

    • Figure Global DFD-10 Consumption and Growth Rate (2017-2022)

    • Figure Global DLX-2323 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global CB-0601 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CJM-112 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CLS-007 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dapsone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DFD-10 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DLX-2323 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Acne Vulgaris Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Acne Vulgaris Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Ensol Biosciences Inc (Foundation Year, Company Profile and etc.)

    • Table Ensol Biosciences Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ensol Biosciences Inc Acne Vulgaris Treatment Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Acne Vulgaris Treatment Product and Service

    • Table Phosphagenics Ltd (Foundation Year, Company Profile and etc.)

    • Table Phosphagenics Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phosphagenics Ltd Acne Vulgaris Treatment Product and Service

    • Table ELORAC Inc (Foundation Year, Company Profile and etc.)

    • Table ELORAC Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table ELORAC Inc Acne Vulgaris Treatment Product and Service

    • Table Dermira Inc (Foundation Year, Company Profile and etc.)

    • Table Dermira Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dermira Inc Acne Vulgaris Treatment Product and Service

    • Table Cutanea Life Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Product and Service

    • Table Foamix Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product and Service

    • Table Galderma SA (Foundation Year, Company Profile and etc.)

    • Table Galderma SA Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galderma SA Acne Vulgaris Treatment Product and Service

    • Table LEO Pharma A/S (Foundation Year, Company Profile and etc.)

    • Table LEO Pharma A/S Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table LEO Pharma A/S Acne Vulgaris Treatment Product and Service

    • Table Hovione FarmaCiencia SA (Foundation Year, Company Profile and etc.)

    • Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Product and Service

    • Table Novabiotics Ltd (Foundation Year, Company Profile and etc.)

    • Table Novabiotics Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novabiotics Ltd Acne Vulgaris Treatment Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Acne Vulgaris Treatment Product and Service

    • Table Lee's Pharmaceutical Holdings Ltd (Foundation Year, Company Profile and etc.)

    • Table Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product and Service

    • Table Helix BioMedix Inc (Foundation Year, Company Profile and etc.)

    • Table Helix BioMedix Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helix BioMedix Inc Acne Vulgaris Treatment Product and Service

    • Table Paratek Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Acne Vulgaris Treatment Product and Service

    • Table Common Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Common Pharma Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Common Pharma Inc Acne Vulgaris Treatment Product and Service

    • Table Novan Inc (Foundation Year, Company Profile and etc.)

    • Table Novan Inc Acne Vulgaris Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novan Inc Acne Vulgaris Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US